Aurora Cannabis (TSX:ACB) remains unprofitable, but has managed to reduce its losses at an impressive rate of 61.2% per year ...

This article first appeared on GuruFocus. Aurora Cannabis Inc (TSX:ACB) is set to release its Q2 2026 earnings on Nov 5, 2025 ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Expands YoY Global Medical Cannabis Net Revenue 1 by 15% to Record $70.5 million Increases International Medical Cannabis Net ...

Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good investment right now? Aurora Cannabis produces and sells a variety of cannabis ...

It’s been a tough few months for Aurora Cannabis (TSX:ACB)(NYSE:ACB) investors. After reaching a peak closing price of $13.26 in April, the stock has been on a gradual but noticeable downtrend, ...

EDMONTON, AB, July 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that its dedicated ...

Announces today the launch of the company's first German-cultivated medical cannabis product, under ... Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical ...

Aurora Cannabis is one of the worlds largest cannabis companies today, currently producing and distributing certified organic medical cannabis in Canada. The company also has a presence or ...